Therapy of coronary disease
Trenkwalder, P.; Lydtin, H.
Deutsche Medizinische Wochenschrift 117(1): 37-38
1992
ISSN/ISBN: 0012-0472 PMID: 1346102 Document Number: 403410
Document emailed within 1 workday
Related Documents
Arntz, H.R.; Wunderlich, W.; Schnitzer, L.; Stern, R.; Fischer, F.; Agrawal, R.; Linderer, T.; Schultheiss, H.P. 1999: Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study Zeitschrift für Kardiologie 88(8): 582-590Leschke, M.; Mecklenbeck, W.; Strauer, B.E. 1992: Chronic intermittent urokinase therapy in inoperable end-stage coronary disease with therapy refractory angina pectoris symptoms Medizinische Klinik 87(7): 385-389
Savonitto, S.; Ambrosini, V.; Marzocchi, A.; Tolaro, S.; Petronio, A.S.; Galassi, A.R.; Bongo, A.S.; Gaglione, A.; Bolognese, L. 2005: Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(2): 106-118
Zhdan, V.; Khaymenova, G.; Shilkina, L.; Martynyuk, D.; Babanina, M.; Mamontova, T. 2017: Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease Wiadomosci Lekarskie 70(2 Part 2): 303-305
Niederberger, M. 1976: Therapy of coronary heart disease Wiener Medizinische Wochenschrift 126(32-35): 469-473
Dietmann, K. 1977: Glycoside therapy in coronary disease Wiener Medizinische Wochenschrift 127(20): 627-630
Stauch, M. 1979: The value of drug therapy in coronary disease ZFA. Zeitschrift für Allgemeinmedizin 55(28): 1577
Hofmeier, G.; Volkmer, I. 1974: Surgical therapy of coronary disease Die Medizinische Welt 25(12): 518-520
Meller, S.M.; Stilp, E.; Walker, C.N.; Mena-Hurtado, C. 2013: The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy Journal of Invasive Cardiology 25(6): 313-319
Visser, J. 1970: The dilemma of anticoagulant therapy in coronary heart disease Nederlands Tijdschrift Voor Geneeskunde 114(29): 1221-1223
Loeliger, E.A. 1970: The dilemma of anticoagulant therapy in coronary heart disease Nederlands Tijdschrift Voor Geneeskunde 114(19): 810-813
Zhu, G. 1996: Problems in interventional therapy of coronary heart disease Zhonghua Nei Ke Za Zhi 35(3): 147-148
Hager, W.D. 1977: Vasodilator therapy in coronary artery disease. Part IIi Arizona Medicine 34(8): 565-567
Meyer, J. 1983: Use of calcium antagonists in the therapy of coronary heart disease Der Internist 24(7): 408-414
Rettig, G. 1980: Beta receptor blockers in the therapy of coronary disease ZFA. Zeitschrift für Allgemeinmedizin 56(9): 600-605
Mehta, J.L. 1982: Platelets and coronary heart disease: therapy update Geriatrics 37(5): 129-34 139
Christandl, B. 1981: Therapy of coronary disease with the beta-blocker betapressin Fortschritte der Medizin 99(36): 1473-1476
Rifkind, B.M.; Levy, R.I. 1974: Does hypolipidemic therapy prevent coronary heart disease? Cardiovascular Clinics 6(2): 1-8
Leschke, M.; Motz, W.; Strauer, B.E. 1986: Hemorheologic therapy applications in coronary heart disease Wiener Medizinische Wochenschrift 136(Special Issue): 17-24
Bolte, H.D. 1978: Therapy using beta-receptor blockaders in coronary disease Der Internist 19(9): 520-526